Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun;42(6):1697-1709.
doi: 10.1007/s11064-017-2261-5. Epub 2017 Apr 18.

Branched-Chain Amino Acids and Brain Metabolism

Justin E Sperringer  1 , Adele Addington  2 , Susan M Hutson  2
Affiliations
Review

Branched-Chain Amino Acids and Brain Metabolism

Justin E Sperringer et al. Neurochem Res. 2017 Jun.

Abstract

This review aims to provide a historical reference of branched-chain amino acid (BCAA) metabolism and provide a link between peripheral and central nervous system (CNS) metabolism of BCAAs. Leucine, isoleucine, and valine (Leu, Ile, and Val) are unlike most other essential amino acids (AA), being transaminated initially in extrahepatic tissues, and requiring interorgan or intertissue shuttling for complete catabolism. Within the periphery, BCAAs are essential AAs and are required for protein synthesis, and are key nitrogen donors in the form of Glu, Gln, and Ala. Leucine is an activator of the mammalian (or mechanistic) target of rapamycin, the master regulator of cell growth and proliferation. The tissue distribution and activity of the catabolic enzymes in the peripheral tissues as well as neurological effects in Maple Syrup Urine Disease (MSUD) show the BCAAs have a role in the CNS. Interestingly, there are significant differences between murine and human CNS enzyme distribution and activities. In the CNS, BCAAs have roles in neurotransmitter synthesis, protein synthesis, food intake regulation, and are implicated in diseases. MSUD is the most prolific disease associated with BCAA metabolism, affecting the branched-chain α-keto acid dehydrogenase complex (BCKDC). Mutations in the branched-chain aminotransferases (BCATs) and the kinase for BCKDC also result in neurological dysfunction. However, there are many questions of BCAA metabolism in the CNS (as well as the periphery) that remain elusive. We discuss areas of BCAA and BCKA metabolism that have yet to be researched adequately.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Neurochem. 1997 Dec;69(6):2312-25 - PubMed
    1. J Biol Chem. 1992 Aug 5;267(22):15681-6 - PubMed
    1. Acta Crystallogr D Biol Crystallogr. 2010 May;66(Pt 5):549-57 - PubMed
    1. J Neurochem. 1992 Aug;59(2):582-90 - PubMed
    1. J Biol Chem. 1974 Aug 25;249(16):5070-9 - PubMed

LinkOut - more resources